• Jennifer A Campbell, Sebastian Linde, Rebekah J Walker, and Leonard E Egede.
• Division of Population Health, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
• J Gen Intern Med. 2024 Nov 1; 39 (15): 305230633052-3063.

ObjectiveTo evaluate the evidence on the relationship between delay discounting and clinical diabetes outcomes, identify current measures, and recommend areas for future work.MethodsA reproducible search using OVID Medline, PsycINFO, PubMed, Science Direct, and Scopus was conducted. Articles published from database creation up to March 2024 were searched. Medical Subject Heading (MeSH) terms and keywords representing delay discounting and diabetes were used. Outcomes included hemoglobin A1c (HbA1c), LDL, body mass index (BMI), blood pressure, quality of life (QOL), psychosocial factors, self-care behaviors, and diabetes complications.ResultsA total of 15 articles met the inclusion criteria and were included for final synthesis. Overall, 14 studies included in this review found a significant relationship between delay discounting and diabetes-related outcomes, such that higher delay discounting is significantly related to worse diabetes outcomes for HbA1c, self-care behaviors, BMI, stress, and quality of life across self-reported measures of delay discounting and delay discounting tasks.ConclusionsEvidence supports the relationship between delay discounting and diabetes-related outcomes and self-care behaviors across measures of delay discounting and type of diabetes. To understand delay discounting as a mechanism driving diabetes outcomes and to develop targeted interventions, additional work using a multidisciplinary approach is needed to validate the construct, identify pathways, and refine intervention approaches that can be tested to improve population health.© 2024. The Author(s), under exclusive licence to Society of General Internal Medicine.

12 keywords...

hide…